{"id":55443,"date":"2025-11-28T12:47:50","date_gmt":"2025-11-28T07:17:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=55443"},"modified":"2025-11-28T12:48:15","modified_gmt":"2025-11-28T07:18:15","slug":"sudeep-pharma-ipo-listing-2","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/","title":{"rendered":"Sudeep Pharma IPO Listing at 23.10% Premium at \u20b9730 Per Share"},"content":{"rendered":"<p><strong>Sudeep Pharma IPO listing: <\/strong>The Sudeep Pharma IPO was subscribed 93.71 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 213.08 times, and non-institutional investors (NIIs) received 116.72 times. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details of the Sudeep Pharma IPO.<\/p><div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#Sudeep_Pharma_IPO\" title=\"Sudeep Pharma IPO&nbsp;\">Sudeep Pharma IPO&nbsp;<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#Sudeep_Pharma_IPO_Listing\" title=\"Sudeep Pharma IPO Listing\">Sudeep Pharma IPO Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#About_the_Sudeep_Pharma_IPO_Listing\" title=\"About the Sudeep Pharma IPO Listing\">About the Sudeep Pharma IPO Listing<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#Sudeep_Pharma_Limited_Financials\" title=\"Sudeep Pharma Limited Financials\">Sudeep Pharma Limited Financials<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#Explanation\" title=\"Explanation\">Explanation<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/sudeep-pharma-ipo-listing-2\/#Recent_Articles\" title=\"Recent Articles\">Recent Articles<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_IPO\"><\/span><strong>Sudeep Pharma IPO&nbsp;<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>It is a book-building issue of 895.00 crore shares, comprising a fresh issue of 0.16 crore shares and an offer-for-sale of 1.35 crore shares. The IPO is expected to be listed on the BSE and NSE, with a tentative listing date of 28th November 2025. The Sudeep Pharma IPO is scheduled to take place from 21st November 2025 to 25th November 2025. The face value of Sudeep Pharma IPO shares is \u20b91 per share, and the IPO price is set at \u20b9563.00 to \u20b9593.00 per share.<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>IPO Open Date<\/strong><\/td><td>21st November 2025<\/td><\/tr><tr><td><strong>IPO Close Date<\/strong><\/td><td>25th November 2025<\/td><\/tr><tr><td><strong>IPO Allotment Date<\/strong><\/td><td>26th November 2025<\/td><\/tr><tr><td><strong>Refund Initiation&nbsp;<\/strong><\/td><td>27th November 2025<\/td><\/tr><tr><td><strong>Face Value<\/strong><\/td><td>\u20b91 per share<\/td><\/tr><tr><td><strong>Price Band<\/strong><\/td><td>\u20b9563 to \u20b9593 per share<\/td><\/tr><tr><td><strong>Lot Size<\/strong><\/td><td>25 Shares<\/td><\/tr><tr><td><strong>Issue Size<\/strong><\/td><td>1,50,92,750 shares(aggregating up to \u20b9895.00 Cr)<\/td><\/tr><tr><td><strong>Fresh Issue<\/strong><\/td><td>16,02,024 shares(aggregating up to \u20b995.00 Cr)<\/td><\/tr><tr><td><strong>Offer for sale&nbsp;<\/strong><\/td><td>1,34,90,726 shares of \u20b91(aggregating up to \u20b9800.00 Cr)<\/td><\/tr><tr><td><strong>Issue Type&nbsp;<\/strong><\/td><td>Bookbuilding IPO<\/td><\/tr><tr><td><strong>Listing At<\/strong><\/td><td>BSE and NSE<\/td><\/tr><tr><td><strong>Listing Date<\/strong><\/td><td>28th November 2025<\/td><\/tr><\/tbody><\/table><\/figure><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_IPO_Listing\"><\/span><strong>Sudeep Pharma IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>On the NSE platforms, Sudeep Pharma shares are listed at \u20b9730 per share, reflecting a 23.10% premium over the issue price of \u20b9593 per share.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"About_the_Sudeep_Pharma_IPO_Listing\"><\/span><strong>About the Sudeep Pharma IPO Listing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>Sudeep Pharma was established in 1989 and is a manufacturer of pharmaceutical excipients, food-grade minerals, and speciality nutrition ingredients serving over 100 countries. The company operates six manufacturing facilities with a combined production capacity of 50,000\u202fMT, specializing in minerals such as calcium, iron, magnesium, zinc, potassium, and sodium. The company supplies over 200 products to a diverse customer base across the pharmaceutical, food, and nutrition sectors. The company has strong R&amp;D capabilities with in-house labs and pilot-scale facilities focused on mineral salts and excipients.<\/p><p>Market leadership with a diversified product portfolio in a high-barrier industry<\/p><p>Distinguished global customer base with long-standing relationships with key customers<\/p><p>Well-equipped and regulatory-compliant Manufacturing Facilities<\/p><p>Intense research and development capabilities<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Sudeep_Pharma_Limited_Financials\"><\/span><strong>Sudeep Pharma Limited Financials<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p>The company&#8217;s financial analysis is essential before applying for <strong>Sudeep Pharma Limited&#8217;s IPO. <\/strong>Refer to the table to learn about Sudeep Pharma Limited&#8217;s financial information.&nbsp;<\/p><figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><tbody><tr><td><strong>Year Ended<\/strong><\/td><td><strong>30th June 2025<\/strong><\/td><td><strong>31st March 2025 (in cr.)<\/strong><\/td><td><strong>31st March 2024 (in cr.)<\/strong><\/td><td><strong>31st March 2023 (in cr.)<\/strong><\/td><\/tr><tr><td><strong>Assets<\/strong><\/td><td>922.26<\/td><td>717.17<\/td><td>513.87<\/td><td>420.11<\/td><\/tr><tr><td><strong>Revenue<\/strong><\/td><td>130.08<\/td><td>511.33<\/td><td>465.38<\/td><td>438.26<\/td><\/tr><tr><td><strong>Profit After Tax<\/strong><\/td><td>31.27<\/td><td>138.69<\/td><td>133.15<\/td><td>62.32<\/td><\/tr><tr><td><strong>EBITDA<\/strong><\/td><td>48.57<\/td><td>199.28<\/td><td>187.76<\/td><td>98.64<\/td><\/tr><tr><td><strong>Net Worth<\/strong><\/td><td>688.32<\/td><td>497.53<\/td><td>359.07<\/td><td>226.29<\/td><\/tr><tr><td><strong>Reserve and Surplus<\/strong><\/td><td>668.52<\/td><td>481.11<\/td><td>354.59<\/td><td>221.88<\/td><\/tr><tr><td><strong>Total Borrowing<\/strong><\/td><td>135.97<\/td><td>135.25<\/td><td>75.03<\/td><td>82.26<\/td><\/tr><\/tbody><\/table><\/figure><h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Explanation\"><\/span><strong>Explanation<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3><p>Sudeep Pharma Limited&#8217;s revenue increased by 10% from \u20b9465.38 crore in March 2024 to \u20b9511.33 crore in March 2025. Moreover, the company\u2019s PAT increased by 4% from \u20b9133.15 crores to \u20b9138.69 crores. Investors can analyse other relevant factors and make a decision accordingly.<\/p><h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Recent_Articles\"><\/span><strong>Recent Articles<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2><p><a href=\"https:\/\/univest.in\/blogs\/penny-stocks-for-long-term\">Best Penny Stocks for Long Term in India | Penny Stocks in 2025<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/berger-paints-q1-results-fy26\">Berger Paints Q1 Results FY26: Q1 PAT Narrows 11.01% to \u20b9314.63 Crore; Revenue Surged 3.55% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/tega-industries-q1-results-fy26\">Tega Industries Q1 Results FY26: Q1 PAT Falls 3.83% to \u20b935.34 Crore; Revenue Jumps 4.74% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/alembic-pharmaceuticals-q1-results-fy26\">Alembic Pharmaceuticals Q1 Results FY26: Q1 PAT Soars 14.60% to \u20b9154.38 Crore; Revenue Up 9.54% YoY<\/a><\/p><p><a href=\"https:\/\/univest.in\/blogs\/bls-international-services-q1-results-fy26\">BLS International Services Q1 Results FY26: Q1 PAT Soars 49.76% to \u20b9171.00 Crore; Revenue Up 44.23% YoY<\/a>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Sudeep Pharma IPO listing: The Sudeep Pharma IPO was subscribed 93.71 times at the time of its closing. In this subscription, qualified institutional buyers (QIBs) received 213.08 times, and non-institutional investors (NIIs) received 116.72 times. The retail quota of the issue was subscribed to 35.00%. Before delving deeper into the topic, go through the details<\/p>\n","protected":false},"author":23,"featured_media":55444,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1281],"tags":[3526],"class_list":["post-55443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","tag-sudeep-pharma-ipo-listing"],"metadata":{"_edit_lock":["1764314295:23"],"_last_editor_used_jetpack":["block-editor"],"rank_math_internal_links_processed":["1"],"rank_math_primary_category":["1281"],"rank_math_seo_score":["77"],"rank_math_title":["Sudeep Pharma IPO Listing Today; Check Share Price in 2025"],"rank_math_description":["Sudeep Pharma IPO Listing at \u20b9730 at a premium of 23.10% against the IPO price of \u20b9593 per share. What should be your next move on the Sudeep Pharma IPO? Read more to know.\r\n"],"rank_math_focus_keyword":["Sudeep Pharma IPO"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["55444"],"_edit_last":["23"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["4851"],"_wp_page_template":["default"],"rs_page_bg_color":[""],"rank_math_canonical_url":["https:\/\/univest.in\/blogs\/sudeep-pharma-ipo-listing-2"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest-blog.storage.googleapis.com\/blogs\/wp-content\/uploads\/2025\/11\/28124534\/Sudeep-Pharma-Listing-Today.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55443","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/23"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=55443"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55443\/revisions"}],"predecessor-version":[{"id":55445,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/55443\/revisions\/55445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/55444"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=55443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=55443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=55443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}